- Type / Class
- Equity / Common Stock
- Shares outstanding
- 21,352,124
- Total 13F shares
- 11,022,797
- Share change
- +2,437,780
- Total reported value
- $84,985,269
- Price per share
- $7.71
- Number of holders
- 76
- Value change
- +$18,818,454
- Number of buys
- 50
- Number of sells
- 20
Quarterly Holders Quick Answers
What is CUSIP 48115J109?
CUSIP 48115J109 identifies DERM - Journey Medical Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 48115J109:
Top shareholders of DERM - Journey Medical Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13D/G
13F
|
Company |
8%
|
1,854,596
|
$14,020,746 | $0 | 31 Mar 2025 | |
| Fortress Biotech, Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,860,467
|
$11,735,820 | — | 12 May 2022 | |
| WASATCH ADVISORS LP |
13F
|
Company |
6.1%
|
1,306,272
|
$9,300,657 | — | 30 Sep 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
4.5%
|
971,064
|
$6,913,976 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
3%
|
633,059
|
$4,507,380 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
615,229
|
$4,380,431 | — | 30 Sep 2025 | |
| Summit Financial, LLC |
13F
|
Company |
1.8%
|
379,829
|
$2,704,382 | — | 30 Sep 2025 | |
| Lindsay A. Rosenwald MD |
3/4/5
|
Director |
1.8%
|
387,616
|
$2,682,302 | — | 05 Aug 2025 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
1.7%
|
354,021
|
$2,520,630 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
277,846
|
$1,978,435 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.2%
|
247,900
|
$1,765,048 | — | 30 Sep 2025 | |
| Pale Fire Capital SE |
13F
|
Company |
1.1%
|
228,567
|
$1,627,397 | — | 30 Sep 2025 | |
| Ernest Robert de Paolantonio |
3/4/5
|
Officer |
—
class O/S missing
|
259,907
|
$1,356,715 | — | 04 Oct 2022 | |
| AMERICAN FINANCIAL GROUP INC |
13F
|
Company |
0.84%
|
180,000
|
$1,281,600 | — | 30 Sep 2025 | |
| Justin Adam Smith |
3/4/5
|
Director |
0.8%
|
171,618
|
$1,187,596 | — | 05 Aug 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.68%
|
146,037
|
$1,039,783 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.68%
|
145,220
|
$1,033,966 | — | 30 Sep 2025 | |
| PVG ASSET MANAGEMENT CORP |
13F
|
Company |
0.62%
|
132,904
|
$946,276 | — | 30 Sep 2025 | |
| Sheets Smith Investment Management |
13F
|
Company |
0.62%
|
132,904
|
$946,276 | — | 30 Sep 2025 | |
| Miranda Jayne Toledano |
3/4/5
|
Director |
0.51%
|
108,618
|
$751,636 | — | 05 Aug 2025 | |
| Neil Herskowitz |
3/4/5
|
Director |
0.51%
|
108,618
|
$751,636 | — | 05 Aug 2025 | |
| Legato Capital Management LLC |
13F
|
Company |
0.48%
|
101,896
|
$725,500 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.43%
|
92,742
|
$660,323 | — | 30 Sep 2025 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.42%
|
89,389
|
$636,450 | — | 30 Sep 2025 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
0.3%
|
63,280
|
$450,554 | — | 30 Sep 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.29%
|
60,950
|
$433,964 | — | 30 Sep 2025 | |
| Michael Cooper Pearce |
3/4/5
|
Director |
0.27%
|
57,173
|
$395,637 | — | 05 Aug 2025 | |
| Jeffrey Paley |
3/4/5
|
Director |
—
class O/S missing
|
70,727
|
$369,195 | — | 28 Nov 2023 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.24%
|
50,834
|
$361,938 | — | 30 Sep 2025 | |
| Creative Planning |
13F
|
Company |
0.24%
|
50,500
|
$359,560 | — | 30 Sep 2025 | |
| Integrated Wealth Concepts LLC |
13F
|
Company |
0.21%
|
44,350
|
$315,772 | — | 30 Sep 2025 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.17%
|
35,838
|
$255,167 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.16%
|
34,053
|
$242,457 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.14%
|
30,451
|
$216,811 | — | 30 Sep 2025 | |
| Gladstone Institutional Advisory LLC |
13F
|
Company |
0.13%
|
28,571
|
$203,426 | — | 30 Sep 2025 | |
| Atria Investments, Inc |
13F
|
Company |
0.12%
|
25,630
|
$182,486 | — | 30 Sep 2025 | |
| Focus Partners Advisor Solutions, LLC |
13F
|
Company |
0.09%
|
20,006
|
$179,054 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
24,492
|
$174,381 | — | 30 Sep 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.11%
|
22,554
|
$160,584 | — | 30 Sep 2025 | |
| Kovitz Investment Group Partners, LLC |
13F
|
Company |
0.1%
|
21,710
|
$154,575 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.1%
|
21,537
|
$153,343 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
20,732
|
$147,612 | — | 30 Sep 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.09%
|
19,732
|
$140,492 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
17,566
|
$125,070 | — | 30 Sep 2025 | |
| BRIGHTON JONES LLC |
13F
|
Company |
0.08%
|
16,842
|
$119,916 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.07%
|
15,710
|
$111,855 | — | 30 Sep 2025 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.07%
|
15,470
|
$110,146 | — | 30 Sep 2025 | |
| SJS Investment Consulting Inc. |
13F
|
Company |
0.07%
|
15,000
|
$106,800 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
14,390
|
$102,457 | — | 30 Sep 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.06%
|
13,810
|
$98,327 | — | 30 Sep 2025 |
Institutional Holders of Journey Medical Corp - Common Stock (DERM) as of Q4 2025
As of 31 Dec 2025,
Journey Medical Corp - Common Stock (DERM) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,022,797 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, WASATCH ADVISORS LP, Opaleye Management Inc., J. Goldman & Co LP, VANGUARD GROUP INC, BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, Pale Fire Capital SE, Summit Financial, LLC, and ESSEX INVESTMENT MANAGEMENT CO LLC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
67
Q4 2025 holders
76
Holder diff
9
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.